Doi T - Search Results

1

[Novel molecular-targeted agents for GIST(Regorafenib etc.)].

Naito Y, Doi T. Naito Y, et al. Among authors: doi t. Gan To Kagaku Ryoho. 2013 Jan;40(1):15-8. Gan To Kagaku Ryoho. 2013. PMID: 23306914 Japanese.

2

[A case of breast cancer with multiple bone metastases improved by high-dose toremifene].

Doi T, Nishiyama K, Wakasugi J, Ootaki S, Kikuchi M, Kubota K, Yamamoto H. Doi T, et al. Gan To Kagaku Ryoho. 2001 Jun;28(6):839-43. Gan To Kagaku Ryoho. 2001. PMID: 11432355 Japanese.

3

[GIST].

Doi T. Doi T. Gan To Kagaku Ryoho. 2008 May;35(5):737-9. Gan To Kagaku Ryoho. 2008. PMID: 18487909 Review. Japanese.

4

[Two cases of KRAS wild-type unresectable or recurrent colorectal cancer effectively treated by cetuximab after progression of prior chemotherapy].

Yoda Y, Yoshino T, Kadowaki S, Bando H, Okano S, Fukushima H, Fuse N, Tahara M, Doi T, Ohtsu A. Yoda Y, et al. Among authors: doi t. Gan To Kagaku Ryoho. 2009 Jun;36(6):1003-6. Gan To Kagaku Ryoho. 2009. PMID: 19542725 Japanese.

5

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate.

Sawaki A, Yamada Y, Komatsu Y, Kanda T, Doi T, Koseki M, Baba H, Sun YN, Murakami K, Nishida T. Sawaki A, et al. Among authors: doi t. Cancer Chemother Pharmacol. 2010 Apr;65(5):961-7. doi: 10.1007/s00280-009-1103-9. Epub 2009 Aug 19. Cancer Chemother Pharmacol. 2010. PMID: 19690858 Free PMC article. Clinical Trial.

6

Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate.

Shirao K, Nishida T, Doi T, Komatsu Y, Muro K, Li Y, Ueda E, Ohtsu A. Shirao K, et al. Among authors: doi t. Invest New Drugs. 2010 Dec;28(6):866-75. doi: 10.1007/s10637-009-9306-9. Invest New Drugs. 2010. PMID: 19730791 Clinical Trial.

7

Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor.

Sawaki A, Nishida T, Doi T, Yamada Y, Komatsu Y, Kanda T, Kakeji Y, Onozawa Y, Yamasaki M, Ohtsu A. Sawaki A, et al. Among authors: doi t. Cancer. 2011 Oct 15;117(20):4633-41. doi: 10.1002/cncr.26120. Epub 2011 Mar 31. Cancer. 2011. PMID: 21456006 Free article. Clinical Trial.

8

Amrubicin for the treatment of neuroendocrine carcinoma of the gastrointestinal tract: a retrospective analysis of five cases.

Asayama M, Fuse N, Yoshino T, Yano T, Tahara M, Doi T, Fujii S, Ohtsu A. Asayama M, et al. Among authors: doi t. Cancer Chemother Pharmacol. 2011 Nov;68(5):1325-30. doi: 10.1007/s00280-011-1619-7. Epub 2011 Apr 3. Cancer Chemother Pharmacol. 2011. PMID: 21461890

9

[Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].

Sato A, Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Koizumi W, Mizunuma N, Takiuchi H. Sato A, et al. Among authors: doi t. Gan To Kagaku Ryoho. 2011 Apr;38(4):561-9. Gan To Kagaku Ryoho. 2011. PMID: 21498982 Clinical Trial. Japanese.

10

[Chemotherapy for GI and pancreatic NETs].

Doi T. Doi T. Gan To Kagaku Ryoho. 2013 Jul;40(7):838-42. Gan To Kagaku Ryoho. 2013. PMID: 23863723 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,633 results

Search Page

Filters